Samantha Archer Stoltz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samantha Archer Stoltz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Elayaraja Kolanthai
Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, Nanoscience Technology Center, Biionix Cluster, College of Medicine, University of Central Florida, Orlando, Florida, USA
2 shared publications - Sudipta Seal
Advanced Materials Processing and Analysis Center, Nanoscience Technology Center, University of Central Florida, Orlando, FL 32826, USA
2 shared publications - Agastya Mittal
College of Medicine, University of Florida, Gainesville, Florida, USA
1 shared publication - Balaashwin Babu
Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, FL 32826, USA
1 shared publication - Craig James Neal
Department of Materials Science and Engineering, University of Central Florida, Orlando, FL, USA
1 shared publication - Melanie Jean Coathup
Biionix Cluster, College of Medicine University of Central Florida Orlando Florida USA
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (25) , 22544-22558
Biomedical utility of zinc and copper mediated cerium oxide nanoparticles
(Copper, Zinc) Metal (oxide)-modified cerium oxide nanoparticles promote cell survival via redox-mediated surface reactions in vitro (HUVEC); while producing a substantial pro-oxidant, cytotoxic effect in a (MCF-7 breast cancer) cancer model.
- 30 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (25) , 22544-22558
Open AccessBiomedical utility of zinc and copper mediated cerium oxide nanoparticles
(Copper, Zinc) Metal (oxide)-modified cerium oxide nanoparticles promote cell survival via redox-mediated surface reactions in vitro (HUVEC); while producing a substantial pro-oxidant, cytotoxic effect in a (MCF-7 breast cancer) cancer model.
- Open Access
- 26 October 2023
- Published by MDPI AG in Preprints.org
Inorganic Nanoparticles as Radiosensitizers for Cancer Treatment
: Nanotechnology has expanded what can be achieved in our approach to cancer treatment. The ability to produce and engineer functional nanoparticle formulations to elicit higher incidences of tumor cell radiolysis has resulted in substantial improvements in cancer cell eradication while also permitting multi-modal biomedical functionalities. These radiosensitive nanomaterials utilize material characteristics, such as radio- blocking/absorbing high-Z atomic number elements, to mediate localized effects from therapeutic irradiation. These materials thereby allow for subsequent scattered or emitted radiation to produce direct (e.g., damage to genetic materials) or indirect (e.g., protein oxidation, reactive oxygen species formation) damage to tumor cells. Using nanomaterials that activate under certain physiologic conditions such as the tumor micro-environment can selectively target tumor cells. These characteristics combined with biological interactions that can target the tumor environment allow for localized, radio-sensitization while mitigating damage to healthy cells. This review explores the various nanomaterial formulations utilized in cancer radiosensitivity research. Emphasis on inorganic nanomaterials showcase the specific material characteristics that enable higher incidences of radiation while ensuring localized cancer targeting based on tumor micro-environment activation. The aim of this review is to guide future research in cancer radiosensitization using nanomaterial formulations and to detail common approaches to radiosensization, as well their relations to commonly implemented radiotherapy techniques.
- 26 October 2023
- Published by MDPI AG in Preprints.org
Open AccessInorganic Nanoparticles as Radiosensitizers for Cancer Treatment
: Nanotechnology has expanded what can be achieved in our approach to cancer treatment. The ability to produce and engineer functional nanoparticle formulations to elicit higher incidences of tumor cell radiolysis has resulted in substantial improvements in cancer cell eradication while also permitting multi-modal biomedical functionalities. These radiosensitive nanomaterials utilize material characteristics, such as radio- blocking/absorbing high-Z atomic number elements, to mediate localized effects from therapeutic irradiation. These materials thereby allow for subsequent scattered or emitted radiation to produce direct (e.g., damage to genetic materials) or indirect (e.g., protein oxidation, reactive oxygen species formation) damage to tumor cells. Using nanomaterials that activate under certain physiologic conditions such as the tumor micro-environment can selectively target tumor cells. These characteristics combined with biological interactions that can target the tumor environment allow for localized, radio-sensitization while mitigating damage to healthy cells. This review explores the various nanomaterial formulations utilized in cancer radiosensitivity research. Emphasis on inorganic nanomaterials showcase the specific material characteristics that enable higher incidences of radiation while ensuring localized cancer targeting based on tumor micro-environment activation. The aim of this review is to guide future research in cancer radiosensitization using nanomaterial formulations and to detail common approaches to radiosensization, as well their relations to commonly implemented radiotherapy techniques.